Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
really? I will call them tomorrow and find out why thye are having trouble with wires from panama to the US
wrong its an either or
well, untill they do explain it you would be crazy to give this company any of your certs
how can u check your balance on the card?
what is the name of the bank in panama? I will call them
RBRM, The CBS review is great. Excellent DD. I didnt see that before
thats absolutely true, there are no new shares hitting and there hasnt been any for at least 2 months
so there u go, no easy way to get your money, if you choose the money card where can you withdraw funds, is their a daily limit, how much is panamersa going to charge you for withdrawals
oh no, I'm not implying anything. I'm telling U its a gods honest fact. I found out when I tried ordering a cert out 2 weeks ago. I'm sure it has to do with Briner's actions, and I'm also quite sure if current financials were filed this would never have happened ( thanks ricky)
What could it be that I have found out. Must be something real bad. Better yet what do the regulators know? I know what they think
no doubt
ok I'm going to ask you all a question. roughly 6-7 weeks ago this stock broke 009 to the down side and volume started drying up. Something happened. the status of WHKA stock changed. Anyone know what a DTC CHILL is ?.
yes I did say that. What do you make of that?
yes thats a very interesting statement
yeah LOL I'm always wrong (sic)
umm, its a little more than talking. I would watch the wires
RBRM has alot of news in the pipeline and I know from my last call to the company that sales are set to double this year over last
we also warned on BUNM last week and guess what??? its down to min bid again .0001 LOL
whaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat?
Yes RBRM is new to the scene but it does have revenues and is making a profit. the financials are filed for anyone to view.
yup RBRM has it coming from what I hear.
RBRM now at .30 x.36
RBRM now .30 x .36
RBRM .30 x .36!!!
thats new. Pinks was quoting it last week
NEWS OUT!@!!!!!!!!!!!!!
RBRM News out!
ReBuilder Medical Technologies, Inc. Announces New Marketing Partner
Company Commits a Minimum of $150,000 to Promote its Products Through New Sales Programs such as infomercials
Jul 24, 2007 10:13:00 AM
CHARLES TOWN, W.Va., July 24 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. (Other OTC: RBRM), an emerging medical device manufacturer founded by world renowned medical device inventor David B. Phillips, Ph.D., today announced it has signed a marketing agreement with Rousseau Associates, LLC. Rousseau Associates' services have been engaged by ReBuilder Medical to develop an infomercial. ReBuilder Medical has committed a budget of $150,000 to this new sales program to promote ReBuilder.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )
"Rousseau has been involved with several sales, marketing and business process advisory positions. By utilizing Rousseau's video marketing supervisory expertise to develop new television programming promoting our existing line of products is another way we are aggressively looking to leverage our products to further enhance our sales," said David B. Phillips, CEO of ReBuilder Medical Technologies, Inc. "We are closely working with the Rousseau Associates to properly promote the ReBuilder with consumers all over the U.S."
About ReBuilder Medical Technologies, Inc.:
ReBuilder Medical Technologies, Inc. is an emerging medical device manufacturer of innovative technologies founded by world renowned medical device inventor David B. Phillips, Ph.D. ReBuilder Medical's flagship product is its FDA registered, ReBuilder System for treating peripheral neuropathy. Unlike current therapies for neuropathy (nerve disease) which focus on prescription drugs with powerful side effects, the ReBuilder System is a portable, battery powered medical product that provides a new non-surgical treatment which is non-invasive, has no side effects and can actually strengthen muscles while increasing blood flow.
ReBuilder Medical also manufactures the Phillips Molluscum Treatment system for treating the skin disease Molluscum Contagiosum which primarily affects children. This system uses its proprietary form of micronized amorphous silver ions to disable the molluscum virus without side effects. The company is currently performing research and development on a number of other products as well.
More information on ReBuilder Medical and its products can be found at: http://www.rebuildermedical.net
Safe Harbor: This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.
SOURCE ReBuilder Medical Technologies, Inc.
RBRM : announces new marketing partner
ReBuilder Medical Technologies, Inc. Announces New Marketing Partner
Company Commits a Minimum of $150,000 to Promote its Products Through New Sales Programs such as infomercials
Jul 24, 2007 10:13:00 AM
CHARLES TOWN, W.Va., July 24 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. (Other OTC: RBRM), an emerging medical device manufacturer founded by world renowned medical device inventor David B. Phillips, Ph.D., today announced it has signed a marketing agreement with Rousseau Associates, LLC. Rousseau Associates' services have been engaged by ReBuilder Medical to develop an infomercial. ReBuilder Medical has committed a budget of $150,000 to this new sales program to promote ReBuilder.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )
"Rousseau has been involved with several sales, marketing and business process advisory positions. By utilizing Rousseau's video marketing supervisory expertise to develop new television programming promoting our existing line of products is another way we are aggressively looking to leverage our products to further enhance our sales," said David B. Phillips, CEO of ReBuilder Medical Technologies, Inc. "We are closely working with the Rousseau Associates to properly promote the ReBuilder with consumers all over the U.S."
About ReBuilder Medical Technologies, Inc.:
ReBuilder Medical Technologies, Inc. is an emerging medical device manufacturer of innovative technologies founded by world renowned medical device inventor David B. Phillips, Ph.D. ReBuilder Medical's flagship product is its FDA registered, ReBuilder System for treating peripheral neuropathy. Unlike current therapies for neuropathy (nerve disease) which focus on prescription drugs with powerful side effects, the ReBuilder System is a portable, battery powered medical product that provides a new non-surgical treatment which is non-invasive, has no side effects and can actually strengthen muscles while increasing blood flow.
ReBuilder Medical also manufactures the Phillips Molluscum Treatment system for treating the skin disease Molluscum Contagiosum which primarily affects children. This system uses its proprietary form of micronized amorphous silver ions to disable the molluscum virus without side effects. The company is currently performing research and development on a number of other products as well.
More information on ReBuilder Medical and its products can be found at: http://www.rebuildermedical.net
Safe Harbor: This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.
SOURCE ReBuilder Medical Technologies, Inc.
WHKA looks good this morning, also check out RBRM. news this morning
RBRM: announces new marketing partner
ReBuilder Medical Technologies, Inc. Announces New Marketing Partner
Company Commits a Minimum of $150,000 to Promote its Products Through New Sales Programs such as infomercials
Jul 24, 2007 10:13:00 AM
CHARLES TOWN, W.Va., July 24 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. (Other OTC: RBRM), an emerging medical device manufacturer founded by world renowned medical device inventor David B. Phillips, Ph.D., today announced it has signed a marketing agreement with Rousseau Associates, LLC. Rousseau Associates' services have been engaged by ReBuilder Medical to develop an infomercial. ReBuilder Medical has committed a budget of $150,000 to this new sales program to promote ReBuilder.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )
"Rousseau has been involved with several sales, marketing and business process advisory positions. By utilizing Rousseau's video marketing supervisory expertise to develop new television programming promoting our existing line of products is another way we are aggressively looking to leverage our products to further enhance our sales," said David B. Phillips, CEO of ReBuilder Medical Technologies, Inc. "We are closely working with the Rousseau Associates to properly promote the ReBuilder with consumers all over the U.S."
About ReBuilder Medical Technologies, Inc.:
ReBuilder Medical Technologies, Inc. is an emerging medical device manufacturer of innovative technologies founded by world renowned medical device inventor David B. Phillips, Ph.D. ReBuilder Medical's flagship product is its FDA registered, ReBuilder System for treating peripheral neuropathy. Unlike current therapies for neuropathy (nerve disease) which focus on prescription drugs with powerful side effects, the ReBuilder System is a portable, battery powered medical product that provides a new non-surgical treatment which is non-invasive, has no side effects and can actually strengthen muscles while increasing blood flow.
ReBuilder Medical also manufactures the Phillips Molluscum Treatment system for treating the skin disease Molluscum Contagiosum which primarily affects children. This system uses its proprietary form of micronized amorphous silver ions to disable the molluscum virus without side effects. The company is currently performing research and development on a number of other products as well.
More information on ReBuilder Medical and its products can be found at: http://www.rebuildermedical.net
Safe Harbor: This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.
SOURCE ReBuilder Medical Technologies, Inc.
RBRM is looking to move in a big way as well
WHKA : added some here this morning looks great
there is no thinking about it, what do you think is going on today
yup adding more here
no news as promised
thats because none of us knew about it.
yes there is no teams going to charels clay. I am totally dismissing it. and if you dont believe me, call him for yourself
too late blackcat
fortunately others are in that position
the CEO is out of time